Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-24-046019
Filing Date
2024-11-12
Accepted
2024-11-12 07:30:43
Documents
81
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ef20034554_10q.htm   iXBRL 10-Q 2720206
2 EXHIBIT 10.45 ef20034554_ex10-45.htm EX-10.45 322911
3 EXHIBIT 10.46 ef20034554_ex10-46.htm EX-10.46 15117
4 EXHIBIT 31.1 ef20034554_ex31-1.htm EX-31.1 15053
5 EXHIBIT 31.2 ef20034554_ex31-2.htm EX-31.2 15061
6 EXHIBIT 32.1 ef20034554_ex32-1.htm EX-32.1 6160
7 EXHIBIT 32.2 ef20034554_ex32-2.htm EX-32.2 6411
  Complete submission text file 0001140361-24-046019.txt   10605614

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA roiv-20240930.xsd EX-101.SCH 75699
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE roiv-20240930_cal.xml EX-101.CAL 88583
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE roiv-20240930_def.xml EX-101.DEF 366743
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE roiv-20240930_lab.xml EX-101.LAB 940891
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE roiv-20240930_pre.xml EX-101.PRE 534389
84 EXTRACTED XBRL INSTANCE DOCUMENT ef20034554_10q_htm.xml XML 1459407
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Filer) CIK: 0001635088 (see all company filings)

EIN.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-40782 | Film No.: 241443309
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)